| Symbol |
Name |
|
AATF
|
apoptosis antagonizing transcription factor
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
ACIN1
|
apoptotic chromatin condensation inducer 1
|
|
ACLY
|
ATP citrate lyase
|
|
ACO1
|
aconitase 1, soluble
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM22
|
ADAM metallopeptidase domain 22
|
|
ADD1
|
adducin 1 (alpha)
|
|
AFAP1L2
|
actin filament associated protein 1-like 2
|
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT1S1
|
AKT1 substrate 1 (proline-rich)
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALYREF
|
Aly/REF export factor
|
|
AMOTL2
|
angiomotin like 2
|
|
ANP32A
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A
|
|
ANXA2
|
annexin A2
|
|
APC
|
adenomatous polyposis coli
|
|
APIP
|
APAF1 interacting protein
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP5
|
aquaporin 5
|
|
AR
|
androgen receptor
|
|
ARHGAP12
|
Rho GTPase activating protein 12
|
|
ARHGAP31
|
Rho GTPase activating protein 31
|
|
ARHGAP42
|
Rho GTPase activating protein 42
|
|
ARHGAP5
|
Rho GTPase activating protein 5
|
|
ARHGEF2
|
Rho/Rac guanine nucleotide exchange factor (GEF) 2
|
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7
|
|
ASIC1
|
acid sensing (proton gated) ion channel 1
|
|
ATF1
|
activating transcription factor 1
|
|
ATF2
|
activating transcription factor 2
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AXIN1
|
axin 1
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BANP
|
BTG3 associated nuclear protein
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCR
|
breakpoint cluster region
|
|
BEX1
|
brain expressed, X-linked 1
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BLNK
|
B-cell linker
|
|
BLVRA
|
biliverdin reductase A
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BTG1
|
B-cell translocation gene 1, anti-proliferative
|
|
BTG2
|
BTG family, member 2
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
CA9
|
carbonic anhydrase IX
|
|
CAD
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CAMK4
|
calcium/calmodulin-dependent protein kinase IV
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV2
|
caveolin 2
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBX3
|
chromobox homolog 3
|
|
CCDC88A
|
coiled-coil domain containing 88A
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCNE1
|
cyclin E1
|
|
CCT2
|
chaperonin containing TCP1, subunit 2 (beta)
|
|
CD163L1
|
CD163 molecule-like 1
|
|
CD19
|
CD19 molecule
|
|
CD226
|
CD226 molecule
|
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex)
|
|
CD4
|
CD4 molecule
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
|
CD84
|
CD84 molecule
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC37
|
cell division cycle 37
|
|
CDC5L
|
cell division cycle 5-like
|
|
CDC7
|
cell division cycle 7
|
|
CDCA5
|
cell division cycle associated 5
|
|
CDCP1
|
CUB domain containing protein 1
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK10
|
cyclin-dependent kinase 10
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK7
|
cyclin-dependent kinase 7
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CENPA
|
centromere protein A
|
|
CETN2
|
centrin, EF-hand protein, 2
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHKA
|
choline kinase alpha
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIB1
|
calcium and integrin binding 1 (calmyrin)
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
CIZ1
|
CDKN1A interacting zinc finger protein 1
|
|
CKAP4
|
cytoskeleton-associated protein 4
|
|
CLSPN
|
claspin
|
|
COPS6
|
COP9 signalosome subunit 6
|
|
CORO1C
|
coronin, actin binding protein, 1C
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSNK1E
|
casein kinase 1, epsilon
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
CTBP1
|
C-terminal binding protein 1
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTNND2
|
catenin (cadherin-associated protein), delta 2
|
|
CTTN
|
cortactin
|
|
CUL5
|
cullin 5
|
|
CUX1
|
cut-like homeobox 1
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DACT1
|
dishevelled-binding antagonist of beta-catenin 1
|
|
DAP3
|
death associated protein 3
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDX5
|
DEAD (Asp-Glu-Ala-Asp) box helicase 5
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DES
|
desmin
|
|
DGKA
|
diacylglycerol kinase, alpha 80kDa
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DIXDC1
|
DIX domain containing 1
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DNM1L
|
dynamin 1-like
|
|
DOCK1
|
dedicator of cytokinesis 1
|
|
DOCK7
|
dedicator of cytokinesis 7
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DPM1
|
dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
E2F1
|
E2F transcription factor 1
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF3H
|
eukaryotic translation initiation factor 3, subunit H
|
|
EIF4B
|
eukaryotic translation initiation factor 4B
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF5
|
eukaryotic translation initiation factor 5
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELF4
|
E74-like factor 4 (ets domain transcription factor)
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ELK3
|
ELK3, ETS-domain protein (SRF accessory protein 2)
|
|
ELK4
|
ELK4, ETS-domain protein (SRF accessory protein 1)
|
|
ENOX2
|
ecto-NOX disulfide-thiol exchanger 2
|
|
EP300
|
E1A binding protein p300
|
|
EPHA3
|
EPH receptor A3
|
|
EPHA4
|
EPH receptor A4
|
|
EPHA5
|
EPH receptor A5
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERF
|
Ets2 repressor factor
|
|
ESPL1
|
extra spindle pole bodies homolog 1 (S. cerevisiae)
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAM64A
|
family with sequence similarity 64, member A
|
|
FBXO5
|
F-box protein 5
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCRL6
|
Fc receptor-like 6
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FER
|
fer (fps/fes related) tyrosine kinase
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FHIT
|
fragile histidine triad
|
|
FLII
|
flightless I homolog (Drosophila)
|
|
FLNA
|
filamin A, alpha
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXA2
|
forkhead box A2
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FOXP3
|
forkhead box P3
|
|
FRS2
|
fibroblast growth factor receptor substrate 2
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FTH1
|
ferritin, heavy polypeptide 1
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GADD45GIP1
|
growth arrest and DNA-damage-inducible, gamma interacting protein 1
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA4
|
GATA binding protein 4
|
|
GIT1
|
G protein-coupled receptor kinase interacting ArfGAP 1
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GPSM2
|
G-protein signaling modulator 2
|
|
GRB14
|
growth factor receptor-bound protein 14
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRB7
|
growth factor receptor-bound protein 7
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GTF2I
|
general transcription factor IIi
|
|
GYS1
|
glycogen synthase 1 (muscle)
|
|
H2AFX
|
H2A histone family, member X
|
|
H2AFY
|
H2A histone family, member Y
|
|
H3F3A
|
H3 histone, family 3A
|
|
HAND1
|
heart and neural crest derivatives expressed 1
|
|
HAS2
|
hyaluronan synthase 2
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HDAC4
|
histone deacetylase 4
|
|
HDAC5
|
histone deacetylase 5
|
|
HDAC7
|
histone deacetylase 7
|
|
HDAC8
|
histone deacetylase 8
|
|
HDAC9
|
histone deacetylase 9
|
|
HDGF
|
hepatoma-derived growth factor
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
HNRNPC
|
heterogeneous nuclear ribonucleoprotein C (C1/C2)
|
|
HOXB7
|
homeobox B7
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
|
IL21R
|
interleukin 21 receptor
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9R
|
interleukin 9 receptor
|
|
ILK
|
integrin-linked kinase
|
|
ING1
|
inhibitor of growth family, member 1
|
|
INSR
|
insulin receptor
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRF2
|
interferon regulatory factor 2
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF8
|
interferon regulatory factor 8
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3BP
|
integrin beta 3 binding protein (beta3-endonexin)
|
|
ITGB4
|
integrin, beta 4
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KDR
|
kinase insert domain receptor
|
|
KHDRBS1
|
KH domain containing, RNA binding, signal transduction associated 1
|
|
KHSRP
|
KH-type splicing regulatory protein
|
|
KIF11
|
kinesin family member 11
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF10
|
Kruppel-like factor 10
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
KRT17
|
keratin 17, type I
|
|
KRT8
|
keratin 8, type II
|
|
KSR1
|
kinase suppressor of ras 1
|
|
LAMTOR5
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
|
|
LAT
|
linker for activation of T cells
|
|
LATS1
|
large tumor suppressor kinase 1
|
|
LATS2
|
large tumor suppressor kinase 2
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LDHA
|
lactate dehydrogenase A
|
|
LDLRAP1
|
low density lipoprotein receptor adaptor protein 1
|
|
LIG1
|
ligase I, DNA, ATP-dependent
|
|
LIMK1
|
LIM domain kinase 1
|
|
LIMK2
|
LIM domain kinase 2
|
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAP1B
|
microtubule-associated protein 1B
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K3
|
mitogen-activated protein kinase kinase 3
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP2K5
|
mitogen-activated protein kinase kinase 5
|
|
MAP2K6
|
mitogen-activated protein kinase kinase 6
|
|
MAP3K2
|
mitogen-activated protein kinase kinase kinase 2
|
|
MAP3K3
|
mitogen-activated protein kinase kinase kinase 3
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK11
|
mitogen-activated protein kinase 11
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPKAP1
|
mitogen-activated protein kinase associated protein 1
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPKAPK5
|
mitogen-activated protein kinase-activated protein kinase 5
|
|
MAPRE2
|
microtubule-associated protein, RP/EB family, member 2
|
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate
|
|
MARK3
|
MAP/microtubule affinity-regulating kinase 3
|
|
MBP
|
myelin basic protein
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM3
|
minichromosome maintenance complex component 3
|
|
MCM3AP
|
minichromosome maintenance complex component 3 associated protein
|
|
MCM7
|
minichromosome maintenance complex component 7
|
|
MCTS1
|
malignant T cell amplified sequence 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED1
|
mediator complex subunit 1
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEF2D
|
myocyte enhancer factor 2D
|
|
MEGF10
|
multiple EGF-like-domains 10
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFN2
|
mitofusin 2
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MLLT4
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MOB1A
|
MOB kinase activator 1A
|
|
MOB1B
|
MOB kinase activator 1B
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MSX2
|
msh homeobox 2
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MXD1
|
MAX dimerization protein 1
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYOCD
|
myocardin
|
|
MYOD1
|
myogenic differentiation 1
|
|
NANOG
|
Nanog homeobox
|
|
NBN
|
nibrin
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NDE1
|
nudE neurodevelopment protein 1
|
|
NDEL1
|
nudE neurodevelopment protein 1-like 1
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NDRG2
|
NDRG family member 2
|
|
NEUROG2
|
neurogenin 2
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFAT5
|
nuclear factor of activated T-cells 5, tonicity-responsive
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFE2
|
nuclear factor, erythroid 2
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFKBIB
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
|
|
NGEF
|
neuronal guanine nucleotide exchange factor
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOX4
|
NADPH oxidase 4
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2C1
|
nuclear receptor subfamily 2, group C, member 1
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NUAK1
|
NUAK family, SNF1-like kinase, 1
|
|
NUMB
|
numb homolog (Drosophila)
|
|
NUTM1
|
NUT midline carcinoma, family member 1
|
|
OCLN
|
occludin
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OPTN
|
optineurin
|
|
OSMR
|
oncostatin M receptor
|
|
PA2G4
|
proliferation-associated 2G4, 38kDa
|
|
PAG1
|
phosphoprotein membrane anchor with glycosphingolipid microdomains 1
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PARP10
|
poly (ADP-ribose) polymerase family, member 10
|
|
PAX3
|
paired box 3
|
|
PBK
|
PDZ binding kinase
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDHA1
|
pyruvate dehydrogenase (lipoamide) alpha 1
|
|
PDK1
|
pyruvate dehydrogenase kinase, isozyme 1
|
|
PDLIM4
|
PDZ and LIM domain 4
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PEAK1
|
pseudopodium-enriched atypical kinase 1
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
|
PGAM1
|
phosphoglycerate mutase 1 (brain)
|
|
PGR
|
progesterone receptor
|
|
PGRMC1
|
progesterone receptor membrane component 1
|
|
PHF20
|
PHD finger protein 20
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIKFYVE
|
phosphoinositide kinase, FYVE finger containing
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PITPNB
|
phosphatidylinositol transfer protein, beta
|
|
PITX2
|
paired-like homeodomain 2
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PLCB3
|
phospholipase C, beta 3 (phosphatidylinositol-specific)
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLD2
|
phospholipase D2
|
|
PLK1
|
polo-like kinase 1
|
|
PLSCR1
|
phospholipid scramblase 1
|
|
PML
|
promyelocytic leukemia
|
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase
|
|
POLDIP3
|
polymerase (DNA-directed), delta interacting protein 3
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
POU3F2
|
POU class 3 homeobox 2
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A
|
|
PPP1R1C
|
protein phosphatase 1, regulatory (inhibitor) subunit 1C
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R5C
|
protein phosphatase 2, regulatory subunit B', gamma
|
|
PRDX1
|
peroxiredoxin 1
|
|
PREX1
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRKD2
|
protein kinase D2
|
|
PRKRA
|
protein kinase, interferon-inducible double stranded RNA dependent activator
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PSEN1
|
presenilin 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTMA
|
prothymosin, alpha
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRA
|
protein tyrosine phosphatase, receptor type, A
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
PTTG2
|
pituitary tumor-transforming 2
|
|
PXN
|
paxillin
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD17
|
RAD17 homolog (S. pombe)
|
|
RAD51
|
RAD51 recombinase
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RALA
|
v-ral simian leukemia viral oncogene homolog A (ras related)
|
|
RALB
|
v-ral simian leukemia viral oncogene homolog B
|
|
RAP1B
|
RAP1B, member of RAS oncogene family
|
|
RAP1GAP
|
RAP1 GTPase activating protein
|
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBL1
|
retinoblastoma-like 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RBM17
|
RNA binding motif protein 17
|
|
RCC1
|
regulator of chromosome condensation 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RGCC
|
regulator of cell cycle
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RMDN3
|
regulator of microtubule dynamics 3
|
|
RNF7
|
ring finger protein 7
|
|
RPA2
|
replication protein A2, 32kDa
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KA6
|
ribosomal protein S6 kinase, 90kDa, polypeptide 6
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RRN3
|
RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae)
|
|
RTKN
|
rhotekin
|
|
RUFY1
|
RUN and FYVE domain containing 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXRA
|
retinoid X receptor, alpha
|
|
SDC4
|
syndecan 4
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SFN
|
stratifin
|
|
SFPQ
|
splicing factor proline/glutamine-rich
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SH2B3
|
SH2B adaptor protein 3
|
|
SH3GL1
|
SH3-domain GRB2-like 1
|
|
SH3PXD2A
|
SH3 and PX domains 2A
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHC3
|
SHC (Src homology 2 domain containing) transforming protein 3
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SIRT1
|
sirtuin 1
|
|
SIRT2
|
sirtuin 2
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD5
|
SMAD family member 5
|
|
SMAD9
|
SMAD family member 9
|
|
SMARCAL1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SMYD2
|
SET and MYND domain containing 2
|
|
SMYD3
|
SET and MYND domain containing 3
|
|
SNAI1
|
snail family zinc finger 1
|
|
SORBS3
|
sorbin and SH3 domain containing 3
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPHK2
|
sphingosine kinase 2
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPIN1
|
spindlin 1
|
|
SPN
|
sialophorin
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRCIN1
|
SRC kinase signaling inhibitor 1
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SSTR2
|
somatostatin receptor 2
|
|
SSTR5
|
somatostatin receptor 5
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STK11
|
serine/threonine kinase 11
|
|
STK3
|
serine/threonine kinase 3
|
|
STK4
|
serine/threonine kinase 4
|
|
STMN1
|
stathmin 1
|
|
SYK
|
spleen tyrosine kinase
|
|
SYN1
|
synapsin I
|
|
TAGLN
|
transgelin
|
|
TBX21
|
T-box 21
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFEB
|
transcription factor EB
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TJP1
|
tight junction protein 1
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TNIK
|
TRAF2 and NCK interacting kinase
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TNKS
|
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase
|
|
TOB1
|
transducer of ERBB2, 1
|
|
TOB2
|
transducer of ERBB2, 2
|
|
TOM1L1
|
target of myb1 (chicken)-like 1
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TRIM28
|
tripartite motif containing 28
|
|
TRIP6
|
thyroid hormone receptor interactor 6
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TSC2
|
tuberous sclerosis 2
|
|
TTK
|
TTK protein kinase
|
|
UBE2A
|
ubiquitin-conjugating enzyme E2A
|
|
UHRF1
|
ubiquitin-like with PHD and ring finger domains 1
|
|
USF1
|
upstream transcription factor 1
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VAV3
|
vav 3 guanine nucleotide exchange factor
|
|
VCP
|
valosin containing protein
|
|
VIL1
|
villin 1
|
|
VIM
|
vimentin
|
|
VRK1
|
vaccinia related kinase 1
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WASF1
|
WAS protein family, member 1
|
|
WASL
|
Wiskott-Aldrich syndrome-like
|
|
WBP2
|
WW domain binding protein 2
|
|
WDR77
|
WD repeat domain 77
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
WWC1
|
WW and C2 domain containing 1
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
YES1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
|
YY1
|
YY1 transcription factor
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZBTB4
|
zinc finger and BTB domain containing 4
|
